EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Ivermectin Effect on In-Hospital Mortality and Need for Respiratory Support in COVID-19 Pneumonia: Propensity Score-Matched Retrospective Study

Jara Llenas-García iD, Alfonso Del Pozo iD, Alberto Talaya iD, Nuria Roig-Sánchez, Noemí Poveda Ruiz iD, Carlos Devesa García iD, Emilio Borrajo Brunete, Inmaculada González Cuello iD, Ana Lucas Dato, Miriam Navarro iD, Philip Wikman-Jorgensen

Viruses · 2023

DOI: 10.3390/v15051138 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Viruses, 2023. Verfasst von Jara Llenas-García und 10 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Service, Hospital Vega Baja, 03314 Orihuela, Spain. Hauptthemen laut MEDLINE: COVID-19, Strongyloides stercoralis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consellería de Sanitat Universal i Salut Pública (Generalitat Valenciana, Spain).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

There is negligible evidence on the efficacy of ivermectin for treating COVID-19 pneumonia. This study aimed to assess the efficacy of ivermectin for pre-emptively treating Strongyloides stercoralis hyperinfection syndrome in order to reduce mortality and the need for respiratory support in patients hospitalized for COVID-19.

Methods

This single-center, observational, retrospective study included patients admitted with COVID-19 pneumonia at Hospital Vega Baja from 23 February 2020 to 14 March 2021. Because strongyloidiasis is endemic to our area, medical criteria support empiric administration of a single, 200 μg/kg dose of ivermectin to prevent Strongyloides hyperinfection syndrome. The outcome was a composite of all-cause in-hospital mortality and the need for respiratory support.

Results

Of 1167 patients in the cohort, 96 received ivermectin. After propensity score matching, we included 192 patients. The composite outcome of in-hospital mortality or need for respiratory support occurred in 41.7% of the control group (40/96) and 34.4% (33/96) of the ivermectin group. Ivermectin was not associated with the outcome of interest (adjusted odds ratio [aOR] 0.77, 95% confidence interval [CI] 0.35, 1.69; p = 0.52). The factors independently associated with this endpoint were oxygen saturation (aOR 0.78, 95% CI 0.68, 0.89, p < 0.001) and C-reactive protein at admission (aOR: 1.09, 95% CI 1.03, 1.16, p < 0.001).

Conclusions

In hospitalized patients with COVID-19 pneumonia, ivermectin at a single dose for pre-emptively treating Strongyloides stercoralis is not effective in reducing mortality or the need for respiratory support measures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Strongyloides stercoralisAnimalsHumansIvermectinRetrospective StudiesHospital MortalityPropensity Score

Stichwörter der Autor:innen

COVID-19SARS-CoV-2Strongyloideshyperinfection syndromeivermectin

Substanzen

Ivermectin

Autor:innen und Institutionen

  • Internal Medicine Service, Hospital Vega Baja, 03314 Orihuela, Spain.
  • Foundation for the Promotion of Health and Biomedical Research of the Valencia Region (FISABIO), 46020 Valencia, Spain.
  • Clinical Medicine Department, Miguel Hernández University, 03202 Elche, Spain.
  • Infectious Diseases Unit, Hospital Reina Sofía, 30003 Murcia, Spain.
  • Hospital Pharmacy Department, Hospital Vega Baja, 03314 Orihuela, Spain.
  • Microbiology Department, Hospital Vega Baja, 03314 Orihuela, Spain.

ORCID-Profile: Jara Llenas-García, Alfonso Del Pozo, Alberto Talaya, Noemí Poveda Ruiz, Carlos Devesa García, Inmaculada González Cuello, Miriam Navarro

Förderung

  • Consellería de Sanitat Universal i Salut Pública (Generalitat Valenciana, Spain)

Zitieren

APA

Llenas-García, J., Del Pozo, A., Talaya, A., Roig-Sánchez, N., Poveda Ruiz, N., Devesa García, C., Borrajo Brunete, E., González Cuello, I., Lucas Dato, A., Navarro, M., & Wikman-Jorgensen, P. (2023). Ivermectin Effect on In-Hospital Mortality and Need for Respiratory Support in COVID-19 Pneumonia: Propensity Score-Matched Retrospective Study. Viruses. https://doi.org/10.3390/v15051138

Vancouver

Llenas-García J, Del Pozo A, Talaya A, Roig-Sánchez N, Poveda Ruiz N, Devesa García C, et al. Ivermectin Effect on In-Hospital Mortality and Need for Respiratory Support in COVID-19 Pneumonia: Propensity Score-Matched Retrospective Study. Viruses. 2023. doi:10.3390/v15051138

BibTeX
@article{LlenasGarca2023,
  author = {Llenas-García, Jara and Del Pozo, Alfonso and Talaya, Alberto and Roig-Sánchez, Nuria and Poveda Ruiz, Noemí and Devesa García, Carlos and Borrajo Brunete, Emilio and González Cuello, Inmaculada and Lucas Dato, Ana and Navarro, Miriam and Wikman-Jorgensen, Philip},
  title = {Ivermectin Effect on In-Hospital Mortality and Need for Respiratory Support in COVID-19 Pneumonia: Propensity Score-Matched Retrospective Study},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15051138}
}
Kostenlos starten →